Patents by Inventor Petra Rengers

Petra Rengers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10036746
    Abstract: The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: July 31, 2018
    Assignee: PROTAGEN AG
    Inventors: Heike Göhler, Petra Rengers, Angelika Lüking, Stefan Müllner
  • Publication number: 20170115288
    Abstract: The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.
    Type: Application
    Filed: January 12, 2017
    Publication date: April 27, 2017
    Inventors: Heike Göhler, Petra Rengers, Angelika LÜKING, Stefan MÜLLNER
  • Patent number: 9588115
    Abstract: The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: March 7, 2017
    Assignee: PROTAGEN AG
    Inventors: Heike Göhler, Petra Rengers, Angelika Lüking, Stefan Müllner